Analysis of small cell lung cancer (SCLC) patients (Pts) treated on cancer therapy evaluation program (CTEP)-sponsored phase I trials: 1992-2012.

被引：0
|
作者：
Forde, Patrick M.
Hooker, Craig M.
Rubinstein, Larry
Hann, Christine L.
Harris, Pamela Jo
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[2] Biometr Res Branch, Bethesda, MD USA
[3] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prophylactic cranial irradiation (PCI) for patients (PTS) with small cell lung cancer (SCLC) in complete remission (CR)
    Arriagada, R
    Monnet, I
    Riviere, A
    SantosMiranda, JA
    Bardet, E
    Laplanche, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 83 - 83
  • [42] Two randomised phase III, double blind, placebo controlled trials of thalidomide in patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
    Lee, S.
    Rudd, R. M.
    Woll, P. J.
    Ottensmeier, C. H.
    James, L. E.
    Gower, N. H.
    Spiro, S. G.
    Jitlal, M.
    Hackshaw, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] A phase II study of S-1 for previously treated small cell lung cancer (SCLC)
    Kudo, K.
    Ohyanagi, F.
    Horiike, A.
    Miyauchi, E.
    Motokawa, I.
    Horai, T.
    Mun, M.
    Sakao, Y.
    Okumura, S.
    Nakagawa, K.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Chemotherapy in elderly patients with advanced lung cancer - part I: General aspects and treatment of small cell lung cancer (SCLC)
    Honecker, F
    Wedding, U
    Bokemeyer, C
    ONKOLOGIE, 2004, 27 (05): : 500 - 505
  • [45] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Phase II study of irinotecan and paclitaxel for patients with recurrent small cell lung cancer (SCLC)
    Owonikoko, T. K.
    Ramalingam, S.
    Forster, J.
    Shuai, Y.
    Evans, T.
    Gooding, W. E.
    Sulecki, M.
    Belani, C. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials
    Levy, Antonin
    Gomez-Roca, Carlos
    Massard, Christophe
    Planchard, David
    Albiges, Laurence
    Bahleda, Ratislav
    Bourgier, Celine
    Deutsch, Eric
    Soria, Jean Charles
    Besse, Benjamin
    ONKOLOGIE, 2013, 36 (06): : 357 - 362
  • [48] Precision medicine for patients with advanced small cell lung cancer treated with novel therapeutic agents in a phase I clinical trials unit
    Lim, Joline S.
    Harris, Samuel J.
    Ameratunga, Malaka
    Sundar, Raghav
    Ang, Joo Ern
    Collins, Dearbhaile
    Chenard-Poirier, Maxime
    Garces, Alvaro I.
    Kaye, Stan B.
    Lopez, Juanita
    Banerji, Udai
    de Bono, Johann S.
    Yap, Timothy A.
    CANCER RESEARCH, 2017, 77
  • [49] The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis G.
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    Castro, Gilberto
    De Marchi, Pedro
    Felip, Enriqueta
    Goto, Yasushi
    Greystoke, Alastair
    Lu, Shun
    Lim, Darren Wan Teck
    Papadimitrakopoulou, Vassiliki
    Reck, Martin
    Solomon, Benjamin J.
    Spigel, David R.
    Tan, Daniel Shao-Weng
    Thomas, Michael
    Yang, James Chih-Hsin
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] AN ANALYSIS OF PATIENT CHARACTERISTICS ASSOCIATED WITH MYELOSUPPRESSION AMONG SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED IN US COMMUNITY CANCER CARE PRACTICES
    Lopez-Gonzalez, L.
    Sanborn, R. E.
    Weerasinghe, R. K.
    Epstein, R. S.
    Parrish, A. S.
    Krenitsky, J.
    Huang, H.
    VALUE IN HEALTH, 2023, 26 (06) : S196 - S197
12345